Niclosamide activates the AMP-activated protein kinase complex containing the β2 subunit independently of AMP
Niclosamide activates the AMP-activated protein kinase complex containing the β2 subunit independently of AMP
复制标题
氯硝柳胺独立于 AMP 激活含有 β2 亚基的 AMP 激活蛋白激酶复合物
DOI:
10.1016/j.bbrc.2020.09.071
复制
发表时间:
2020
期刊:
影响因子:
--
通讯作者:
Yuji Yamamoto
中科院分区:
文献类型:
--
作者:
Tsukasa Suzuki;Momoko Kojima;Yu Matsumoto;Ken-Ichi Kobayashi;Jun Inoue;Yuji Yamamoto
AMP-activated protein kinase (AMPK) regulates cellular energy homeostasis by suppressing anabolic processes and activating catabolic processes. AMPK activators are an important therapeutic target for metabolic syndrome due to favorable physiological effects of AMPK activation on metabolism. Recent studies show that niclosamide, an FDA-approved anthelmintic drug that exerts an uncoupling effect on the mitochondria of the parasite, improves blood glucose levels and reduces hepatic steatosis in mice via AMPK activation. Niclosamide is thought to activate AMPK by increasing AMP/ATP ratio through mitochondrial uncoupling, but details of its action remain unclear. In this study, we found that niclosamide also activates the AMPK complex, which contains the AMP-insensitive γ subunit. Further, niclosamide shows greater AMPK activation for the AMPK complex containing β2 subunit, but not the β1 subunit. This effect was inhibited by substituting the Ser108 residue of the β2 subunit to alanine. Niclosamide displays a novel AMPK activation mechanism independent of the increase in AMP/ATP ratio.